Skip to main content

Hyperthermia

  • Chapter
  • First Online:
Book cover Clinical Manual of Fever in Children
  • 1147 Accesses

Abstract

Hyperthermia is a state of thermoregulatory failure resulting from excessive heat production with a normal rate of heat loss (e.g. malignant hyperthermia) or inability to dissipate heat at a sufficient rate (e.g. heat stroke). Dehydration is the most common cause of mild hyperthermia. Hyperthermia may coexist with fever: e.g. dehydration may occur on top of fever due to infection.

In contrast to fever, hyperthermia is not mediated by pyrogen or interleukin-1 (IL-1), and the body temperature is higher than the hypothalamic set point, which is usually normal. Because hyperthermia is not regulated centrally, a temperature in excess of 42 °C is common, and the presence of such degree makes hyperthermia a likely diagnosis. This very high degree of temperature rarely occurs, if ever, with fever alone, even with the most severe infections.

Hyperthermia caused by increased heat production includes physiologically exercise-induced hyperthermia, pathologically malignant hyperthermia, neuroleptic malignant syndrome, serotonin syndrome, drug-induced hyperthermia, and endocrine hyperthermia. Hyperthermia caused by decreased heat loss includes neonatal hyperthermia, heat stroke, haemorrhagic shock and encephalopathy, sudden infant death syndrome (SIDS) and drug-induced hyperthermia. Heat stroke is due to failure of the heat-regulating mechanisms of the hypothalamus subsequent to inhibition of sweating. It is defined as a core temperature greater than 40.6 °C, accompanied by hot, dry skin and CNS abnormalities such as convulsion, delirium and coma. The two principal causes of heat stroke are high ambient temperature and water deprivation. If the temperature rises above 40.2 °C, cell deaths occur, and the condition is associated with high mortality of around 80%.

The chapter also describes “unclassified hyperthermia” such as factitious fever, induced illness and induced illness by proxy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

Clinical Effects of Hyperthermia

  1. Bynum GD, Pandolf KB, Schuette WH, et al. Induced hyperthermia in sedated humans and the concept of critical thermal maximum. Am J Phys. 1978;235:R228–36.

    CAS  Google Scholar 

Exercise-Induced Hyperthermia

  1. Bar-Or O. Climate and the exercising child-review. Int J Sports Med. 1980;1:53–65.

    Article  Google Scholar 

  2. Committee on sports medicine. Climatic heat stress and the exercising child. Pediatrics. 1982;69:808–9.

    Google Scholar 

Malignant Hyperthermia (MH)

  1. Girard T, Joehr M, Schaefer C, et al. Perinatal diagnosis of malignant hyperthermia susceptibility. Anesthesiology. 2006;104:1353–6.

    Article  Google Scholar 

Neuroleptic Malignant Syndrome (NMS)

  1. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993;77:185–202.

    Article  CAS  Google Scholar 

  2. Nierenberg D, Disch M, Manheimer E, et al. Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome. Clin Pharmacol Ther. 1991;50:580–6.

    Article  CAS  Google Scholar 

  3. Oruch R, Pryme IF, Engelsen BA, et al. Neuroleptic malignant syndrome: an easily overlooked neurologic emergency. Neuropsychiatr Dis Treat. 2017;13:161–75.

    Article  CAS  Google Scholar 

Serotonin Syndrome

  1. Halloran L, Bernard DW. Management of drug-induced hyperthermia. Curr Opin Pedaitr. 2004;16:211–5.

    Article  Google Scholar 

Endocrine Hyperthermia

  1. Simon HB, Daniels GH. Hormonal hyperthermia, endocrinological causes of fever. Am J Med. 1979;66:257–63.

    Article  CAS  Google Scholar 

  2. Kilbane BJ, Mehta S, Backeljauw PF, et al. Approach to management of malignant hyperthermia-like syndrome in pediatric diabetes mellitus. Pediatr Crit Care Med. 2006;7:169–73.

    Article  Google Scholar 

  3. Goodman EL, Knochel JP. Endocrine hyperthermia. Heat stroke and other forms of hyperthermia. In: Mackowiak P, editor. Fever: basic mechanisms and management. New York: Raven Press; 1991. p. 281.

    Google Scholar 

Neonatal Hyperthermia

  1. Ws C. The early detection of pyrexia in the newborn. Arch Dis Child. 1963;38:29–39.

    Article  Google Scholar 

Heat Stroke

  1. Knochel JP. Environmental heat loss. Arch Intern Med. 1974;133:841–65.

    Article  CAS  Google Scholar 

  2. McLaren C, Null J, Quinn J. Heat stroke from enclosed vehicles: moderate ambient temperatures cause significant temperature rise in enclosed vehicles. Pediatrics. 2005;116:217.

    Article  Google Scholar 

  3. Ferrara P, Vena F, Caporale O, et al. Children left unattended in parked vehicles: a focus on recent Italian cases and a review of literature. Ital J Pediatr. 2013;39:71.

    Article  Google Scholar 

  4. Van Gestel JPJ, L’Hoir MP, ten-Berge M, et al. Risk of ancient parties in modern times. Pediatrics. 2002;110(6):1–3.

    Google Scholar 

Hemorrhagic Shock and Encephalopathy (HSE)

  1. Levin M, Kay JDS, Gould JD, et al. Hemorrhagic shock and encephalopathy. A new syndrome with high mortality in young children. Lancet. 1983;2:64–7.

    Article  CAS  Google Scholar 

  2. Levin M, Pincott JR, Hjelm M, et al. Haemorrhagic shock and encephalopathy: clinical, pathologic, and biochemical features. J Pediatr. 1989;114:194–203.

    Article  CAS  Google Scholar 

Drug-Induced Hyperthermia

  1. Grosso S, Franzoni E, Iannetti P, et al. Efficacy and safety of topiramate in refractory epilepsy. J Child Neurol. 2005;20:893–7.

    Article  Google Scholar 

Unclassified Hyperthermia

    Sudden Death Infant Syndrome (SIDS)

    1. American Academy of Pediatrics. The changing concept of SIDS: diagnosis, coding shifts, controversies regarding the sleeping environment. New variables to consider in reducing risk. Pediatrics. 2005;116:1245–55.

      Article  Google Scholar 

    2. Blair PS, Sidebotham P, Berry PJ, et al. Major epidemiological changes in SIDS: a 20-year population-based study in the UK. Lancet. 2006;367:314–9.

      Article  Google Scholar 

    3. Stanton AN. Overheating and cot death. Lancet. 1984;3:1199–201.

      Article  Google Scholar 

    Factitious Hyperthermia

    1. Rumans LW, Vosti KL. Factitious and fraudulent fever. Am J Med. 1978;65:745–55.

      Article  CAS  Google Scholar 

    2. Edwards MS, Butler KM. Hyperthermia of trickery in an adolescent. Pediatr Infect Dis J. 1987;6:411–4.

      Article  CAS  Google Scholar 

    Induced Illness

    1. Asher R. Munchausen’s syndrome. Lancet 1951; 1: 339–41.

      Article  Google Scholar 

    2. Sneed RC, Bell RF. The dauphin of Munchausen: factitious passage of renal stones in a child. Pediatrics. 1976;58:127–30.

      CAS  PubMed  Google Scholar 

    3. Libow JA. Child and adolescent illness falsification. Pediatrics. 2000;105:336–42.

      Article  CAS  Google Scholar 

    Induced Illness by Proxy

    1. Meadow R. Munchausen syndrome by proxy: the hinterland of child abuse. Lancet. 1977;2:343–5.

      Article  CAS  Google Scholar 

    2. Meadow R. Munchausen syndrome by proxy. Arch Dis Child. 1982;57:92–8.

      Article  CAS  Google Scholar 

    3. Bools CN, Neale BA, Meadow SR. Co-morbidity associated with fabricated illness (Munchausen syndrome by proxy). Arch Dis Child. 1992;67:77–9.

      Article  CAS  Google Scholar 

    Therapeutic Effects of Hyperthermia

    1. Yerurshalmi A, Lwoff A. Traitement du coryza infectieux et des rhinitis persistantes allergiques par la thermotherapy. Camp Rendus Seances Acad Sci (Paris). 1980;291(Ser D):957–9.

      Google Scholar 

    2. Pennypacker C, Perelson AS, Nys N. Localized or systemic in vivo heat inactivation of HIV: a mathematical analysis. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:321–9.

      Article  CAS  Google Scholar 

    3. Ismail ZRS, Zhavrid EA, Potapnev MP. Whole body hyperthermia in adjuvant therapy of children with renal cell carcinoma. Pediatr Blood Cancer. 2005;44:679–81.

      Article  Google Scholar 

    4. Shields CL, Meadows AT, Leahey AM, et al. Continuing challenges in the management of retinoblastoma with chemotherapy. Retina. 2004;24:849–62.

      Article  Google Scholar 

    5. Seifert G, Budach V, Keilholz U, et al. Regional hyperthermia combined with chemotherapy in paediatric, adolescents, and young adult patients: current and future perspectives. Radiat Oncol. 2016;11:65.

      Article  Google Scholar 

    6. Man J, Shoemake J, Ma T, et al. Hyperthermia sensitizes glioma stem-like cells to radiation by inhibiting AKT signaling. Cancer Res. 2015;75(8):1760–9.

      Article  CAS  Google Scholar 

    Download references

    Author information

    Authors and Affiliations

    Authors

    Editor information

    Editors and Affiliations

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2018 Springer International Publishing AG, part of Springer Nature

    About this chapter

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this chapter

    El-Radhi, A.S. (2018). Hyperthermia. In: El-Radhi, A. (eds) Clinical Manual of Fever in Children. Springer, Cham. https://doi.org/10.1007/978-3-319-92336-9_2

    Download citation

    • DOI: https://doi.org/10.1007/978-3-319-92336-9_2

    • Published:

    • Publisher Name: Springer, Cham

    • Print ISBN: 978-3-319-92335-2

    • Online ISBN: 978-3-319-92336-9

    • eBook Packages: MedicineMedicine (R0)

    Publish with us

    Policies and ethics